LIVERAS YACHTS LIMITED
Company number 13014805 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
LIVERAS YACHTS LIMITED - Analysis Report
Company Number: 13014805
Analysis Date: 2025-07-29 20:58 UTC
Financial Health Assessment: LIVERAS YACHTS LIMITED (As of 30 November 2023)
1. Financial Health Score: D
Explanation:
The company exhibits persistent negative net current assets and shareholders’ funds over four consecutive years, indicating ongoing financial distress. While it remains active and compliant with filing deadlines, the balance sheet reveals a weak financial position that raises concerns about liquidity and solvency.
2. Key Vital Signs
| Metric | 2023 (£) | 2022 (£) | Trend | Interpretation |
|---|---|---|---|---|
| Current Liabilities | 1,966 | 1,413 | ↑ (increasing) | Rising short-term debts place pressure on available resources to meet immediate obligations. |
| Net Current Assets | (1,966) | (1,413) | ↓ (worsening) | Negative working capital shows inability to cover short-term liabilities with short-term assets—a symptom of cash flow stress. |
| Total Assets Less Current Liabilities | (1,966) | (1,413) | ↓ (worsening) | Indicates overall negative net assets, a sign of insolvency risk. |
| Shareholders’ Funds | (2,066) | (1,513) | ↓ (worsening) | Negative equity signals accumulated losses exceeding capital invested—akin to critical organ failure in business health. |
| Share Capital | 100 | 100 | Stable | Minimal capital base, which limits financial resilience. |
| Employee Count | 1 | 1 | Stable | Very small workforce, possibly limiting operational capacity. |
3. Diagnosis
Symptom Analysis:
Liveras Yachts Limited shows persistent symptoms of financial distress:
Negative Working Capital: The company’s current liabilities exceed current assets by £1,966 in 2023, worsening from previous years. This implies immediate liquidity constraints and potential difficulties in meeting short-term debts as they fall due.
Negative Shareholders’ Funds: Equity has deteriorated to a negative £2,066, revealing accumulated losses and erosion of investor capital. This condition is comparable to a patient with critical organ damage—signaling serious financial health issues.
Increasing Current Liabilities: The rise in short-term obligations without corresponding asset growth suggests the company may be relying on borrowing or delayed payments to sustain operations—a risky strategy that can exacerbate financial strain.
Minimal Capitalization: With just £100 in share capital, the company lacks a robust capital buffer to absorb losses or invest in growth.
No Audit Requirement: As a small company, it is exempt from audit, which limits external verification of financial health but does not mitigate the red flags in the accounts.
Overall Diagnosis:
The company is in a precarious financial position, characterized by negative net current assets and shareholders’ deficit. These symptoms point to ongoing cash flow problems and potential solvency risks. Without intervention, these conditions could lead to insolvency or forced restructuring.
4. Recommendations
To improve financial wellness, the company should consider the following actions:
Strengthen Liquidity: Improve cash flow management by accelerating receivables, negotiating extended payment terms with suppliers, or injecting short-term working capital to cover current liabilities.
Capital Injection: Seek additional equity investment or shareholder loans to restore positive shareholders’ funds, providing a financial cushion and restoring confidence among creditors.
Cost Control: Evaluate operational expenses and overhead to reduce cash outflows, possibly rationalizing activities or resources to align with revenue capacity.
Financial Forecasting: Develop robust cash flow projections and scenario planning to anticipate liquidity gaps and plan financing needs proactively.
Engage Professional Advice: Consult insolvency or restructuring professionals early if the liquidity position does not improve, to explore formal rescue or turnaround options.
Enhance Transparency: While audit exemption applies, consider voluntary external review or enhanced internal controls to reassure stakeholders about financial integrity.
Medical Analogy Summary
Liveras Yachts Limited's financial health shows clear "symptoms of distress," such as a "deficient cash flow" and "negative equity," analogous to a patient with failing organs requiring urgent intervention. Without "treatment" in the form of capital support and tighter cash management, the company's "condition" may deteriorate further, risking "financial collapse."
Sign in to generate a free AI analysis of this company — no password needed, just an email link.